Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat for Weight Loss and PBB Reduction in Exposed Population
NCT03582722Phase 4Completed
- Sponsor
- Emory University
- Start
- Sep 2018
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of orlistat in polybrominated biphenyl poisoning, sponsored by Emory University. Started Sep 2018; status: completed.
02
Drugs
orlistat
03
Conditions
polybrominated biphenyl poisoning
Beyond the preview
Go deeper on NCT03582722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03582722.